Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform

Abstract Background Socioeconomic differences in receipt of adjuvant treatment contribute to persistent disparities in breast cancer (BCA) outcomes, including survival. Adjuvant endocrine therapy (AET) substantially reduces recurrence risk and is recommended by clinical guidelines for nearly all wom...

Full description

Bibliographic Details
Main Authors: Kirsten Y. Eom, G. J. van Londen, Jie Li, Bassam Dahman, Cathy Bradley, Lindsay M. Sabik
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-08149-0